There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agenus (AGEN) and Pfenex (PFNX) with bullish sentiments.
Agenus (AGEN)
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Agenus today and set a price target of $8.00. The company’s shares closed last Thursday at $3.31.
According to TipRanks.com, Mamtani is a 5-star analyst with an average return of 14.1% and a 49.3% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals.
Agenus has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.
See today’s analyst top recommended stocks >>
Pfenex (PFNX)
The company’s shares closed last Thursday at $7.42.
According to TipRanks.com, Brisebois is a 3-star analyst with an average return of 8.6% and a 37.2% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Avadel Pharmaceuticals, Flexion Therapeutics, and Kala Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Pfenex with a $14.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
